{"product_id":"kodk-vrio-analysis","title":"Eastman Kodak Company (KODK): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eUnlock the secrets to Eastman Kodak Company (KODK)'s sustained success by diving into this essential VRIO Analysis. We distill the core findings - Value, Rarity, Inimitability, and Organization - into the critical summary found in \u0026amp;O4\u0026amp;, revealing exactly where this business's competitive edge lies. Read on to grasp the strategic implications immediately.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 1: Coating and Layering Science Expertise\n\u003c\/h2\u003e\n\u003cp\u003eYou’re looking at Eastman Kodak Company’s deep technical moat, and honestly, it’s centered on how they put stuff on stuff. This coating and layering science expertise is the engine behind their pivot, which is showing up in the numbers.\u003c\/p\u003e\n\u003cp\u003eThe Advanced Materials \u0026amp; Chemicals (AM\u0026amp;C) segment is the proof point here. For Q3 2025, AM\u0026amp;C brought in $82 million in revenue, which is a solid 15% jump year-over-year from Q3 2024’s $71 million. That’s not just film remnants; that’s real, growing specialty materials business.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math on the capability’s performance:\u003c\/p\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eMetric\u003c\/td\u003e\n    \u003ctd\u003eQ3 2025 Value\u003c\/td\u003e\n    \u003ctd\u003eYear-over-Year Change\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eAM\u0026amp;C Revenue\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$82 million\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e+15%\u003c\/strong\u003e\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eAM\u0026amp;C Operational EBITDA\u003c\/td\u003e\n    \u003ctd\u003e\u003cstrong\u003e$16 million\u003c\/strong\u003e\u003c\/td\u003e\n    \u003ctd\u003e\n\u003cstrong\u003e+167%\u003c\/strong\u003e (from $6 million in Q3 2024)\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003eWhat this estimate hides is the sheer difficulty of replicating the know-how that got them to those numbers. It’s not just a recipe; it’s decades of trial and error baked into the process.\u003c\/p\u003e\n\u003ch\u003eVRIO Assessment\u003c\/h\u003e\n\u003cp\u003eThis capability scores high across the board, which is why it’s a sustained advantage. If onboarding takes 14+ days, churn risk rises, but Kodak is trying to mitigate that specific risk.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eValue: Fuels AM\u0026amp;C segment growth.\u003c\/li\u003e\n\u003cli\u003eRarity: Historical precision coating knowledge is scarce.\u003c\/li\u003e\n\u003cli\u003eImitability: High barrier due to proprietary processes.\u003c\/li\u003e\n\u003cli\u003eOrganization: High, evidenced by reinvestment and retention plans.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe organization is actively managing the transition of this deep knowledge. They announced that Terry Taber, SVP of AM\u0026amp;C and CTO, is retiring effective January 2, 2026, after 45 years, but he will stay on as a consultant for $25,000 per quarter to help hand off responsibilities. That’s a smart, defintely necessary move to keep the science flowing.\u003c\/p\u003e\n\u003ch\u003eCompetitive Implications\u003c\/h\u003e\n\u003cp\u003eThis expertise translates directly into a \u003cstrong\u003eSustained Competitive Advantage\u003c\/strong\u003e because the barrier to entry for competitors trying to match their high-precision output is immense. They are using this foundation to build out profitable new revenue streams.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFoundation for specialty materials success.\u003c\/li\u003e\n\u003cli\u003eDrives high margin in AM\u0026amp;C.\u003c\/li\u003e\n\u003cli\u003eRequires active knowledge transfer planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFinance: Draft a sensitivity analysis on Taber’s consulting cost vs. Q3 2025 AM\u0026amp;C EBITDA by Friday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 2: FDA-Registered cGMP Pharmaceutical Manufacturing Facility\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCore Capability 2: FDA-Registered cGMP Pharmaceutical Manufacturing Facility\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eValue: Opens access to high-margin, regulated pharmaceutical starting materials and devices, a significant step beyond unregulated components.\u003c\/p\u003e\n\u003cp\u003eRarity: Moderate to High. Having an operational, FDA-registered Current Good Manufacturing Practice (cGMP) facility in the U.S. is a high barrier to entry for competitors.\u003c\/p\u003e\n\u003cp\u003eImitability: High. The regulatory hurdles, validation time, and capital investment make imitation slow and costly. The project was supported by a federal loan of \u003cstrong\u003e$765 million\u003c\/strong\u003e in 2020, and the cost for the new lab and manufacturing facility was indicated to be 'in the tens of millions of dollars'.\u003c\/p\u003e\n\u003cp\u003eOrganization: High. Management has clearly prioritized and completed this facility, which began operation in 2025. The facility was reported as registered with the FDA and certified to manufacture and sell regulated pharmaceutical products as of Q2 2025.\u003c\/p\u003e\n\u003cp\u003eCompetitive Advantage: Temporary to Sustained. It's a strong advantage now, but sustained only if they rapidly scale production and secure long-term contracts. For context, Kodak ended Q2 2025 with a cash balance of \u003cstrong\u003e$155 million\u003c\/strong\u003e and reported an Operational EBITDA of \u003cstrong\u003e$9 million\u003c\/strong\u003e for the quarter.\u003c\/p\u003e\n\u003cp\u003eThe facility's specifications and initial focus areas are detailed below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eSpecification Category\u003c\/th\u003e\n\u003cth\u003eDetail\u003c\/th\u003e\n\u003cth\u003eValue\/Status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFacility Size\u003c\/td\u003e\n\u003ctd\u003eSquare Footage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e30,000 square feet\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapacity\u003c\/td\u003e\n\u003ctd\u003eManufacturing Capacity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eone million liters per year\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory Status\u003c\/td\u003e\n\u003ctd\u003eFDA Registration\u003c\/td\u003e\n\u003ctd\u003eRegistered as of Q2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInitial Product Focus\u003c\/td\u003e\n\u003ctd\u003eClass 1 and Class 2 Medical Devices\u003c\/td\u003e\n\u003ctd\u003ePhosphate Buffered Saline (PBS) for laboratory use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFuture Product Target\u003c\/td\u003e\n\u003ctd\u003eRegulated Specialty Products\u003c\/td\u003e\n\u003ctd\u003eInjectable IV saline\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe operational setup includes specific process utility systems:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eWater for injection (WFI) including pre-treatment system and distillation.\u003c\/li\u003e\n\u003cli\u003eClean steam.\u003c\/li\u003e\n\u003cli\u003ePurified process air.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe manufacturing process flow involves several distinct steps:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eProcess Starts\u003c\/li\u003e\n\u003cli\u003eRaw material storage\u003c\/li\u003e\n\u003cli\u003eSolids dispensing\u003c\/li\u003e\n\u003cli\u003eMixing \u0026amp; holding\u003c\/li\u003e\n\u003cli\u003eFilling \u0026amp; capping\u003c\/li\u003e\n\u003cli\u003eLabeling \u0026amp; packaging\u003c\/li\u003e\n\u003cli\u003eInspection \u0026amp; storage\u003c\/li\u003e\n\u003cli\u003eShip to Customer\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 3: Lithographic Printing Plates (SONORA Process Free)\n\u003c\/h2\u003e\n\u003ch4\u003eValue\u003c\/h4\u003e\n\u003cp\u003ePrint Operational EBITDA was \u003cstrong\u003e$8 million\u003c\/strong\u003e in Q3 2025, an increase of \u003cstrong\u003e$17 million\u003c\/strong\u003e compared to negative \u003cstrong\u003e$9 million\u003c\/strong\u003e in Q3 2024. Print revenues for Q3 2025 were \u003cstrong\u003e$177 million\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003ctd\u003eQ3 2024\u003c\/td\u003e\n\u003ctd\u003eChange\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrint Operational EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e-$9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e+$17 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrint Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$177 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$182 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e-$5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch4\u003eRarity\u003c\/h4\u003e\n\u003cp\u003eKodak is the \u003cstrong\u003eonly\u003c\/strong\u003e remaining manufacturer of aluminum-based offset printing plates in the U.S. The KODAK SONORA Process Free Plates for the Americas are manufactured solely at the Columbus, Georgia facility.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe Columbus, GA plant employs approximately \u003cstrong\u003e225\u003c\/strong\u003e workers.\u003c\/li\u003e\n\u003cli\u003eThe facility has invested over \u003cstrong\u003e$28 million\u003c\/strong\u003e in manufacturing lines.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eImitability\u003c\/h4\u003e\n\u003cp\u003eManufacturing involves complex treatments such as graining, anodizing, precision polymer coatings, and image layer application.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSONORA XTRA Plates can deliver up to \u003cstrong\u003e400,000\u003c\/strong\u003e impressions on web-fed presses.\u003c\/li\u003e\n\u003cli\u003eThe technology has been adopted by over \u003cstrong\u003e6,000+\u003c\/strong\u003e businesses worldwide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eOrganization\u003c\/h4\u003e\n\u003cp\u003eThe Print segment's profitability swung from negative \u003cstrong\u003e$9 million\u003c\/strong\u003e in Q3 2024 to positive \u003cstrong\u003e$8 million\u003c\/strong\u003e in Q3 2025. Consolidated Gross Profit increased \u003cstrong\u003e51 percent\u003c\/strong\u003e to \u003cstrong\u003e$68 million\u003c\/strong\u003e in Q3 2025.\u003c\/p\u003e\n\u003ch4\u003eCompetitive Advantage\u003c\/h4\u003e\n\u003cp\u003eAntidumping (AD) and Countervailing Duty (CVD) orders were imposed on imports from Japan at a rate of \u003cstrong\u003e91.83 percent\u003c\/strong\u003e and on imports from China with a combined rate of \u003cstrong\u003e151.51 percent\u003c\/strong\u003e. Aluminum sheet is the printing plates' \u003cstrong\u003esingle largest raw material cost\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 4: Retained Intellectual Property Portfolio (Approx. 9,600 Patents)\n\u003c\/h2\u003e\n\u003cp\u003eThe retained Intellectual Property Portfolio is supported by 79,000 worldwide patents earned over 130 years of Research \u0026amp; Development as of March 14, 2024.\u003c\/p\u003e\n\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eThe IP portfolio provides design freedom for new products in printed electronics and 3D materials, and defends existing core businesses. The Brand segment includes licensing of the Kodak brand to third parties.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFinancial Metric\u003c\/th\u003e\n\u003cth\u003e2024 (Full Year)\u003c\/th\u003e\n\u003cth\u003e2023 (Full Year)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Net Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.043 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.117 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAAP Net Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$102 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$75 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-End Cash Balance\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$201 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$255 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eThe remaining patent base is highly specialized and core to current operations, following the sale of the digital imaging patents for approximately \u003cstrong\u003e$525 million\u003c\/strong\u003e in 2012.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTotal Patents Earned (Cumulative): \u003cstrong\u003e79,000\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eTotal Assets (as of 2024): \u003cstrong\u003e$2.0 billion\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eThe value resides in the application of specific, older patents, which is hard to imitate without the underlying knowledge base. The technologies supporting Kodak's major products are supported by an aggregation of patents and know-how.\u003c\/p\u003e\n\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eThe company is actively planning to capitalize on this IP through new business\/licensing opportunities. The Kodak Research Laboratories conduct research and file patent applications for inventions such as printed electronics.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNet Sales for Industrial Film and Chemicals (which includes R\u0026amp;D\/IP focus): \u003cstrong\u003e18%\u003c\/strong\u003e of total net revenue for the year ended December 31, 2023.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eThe advantage is valuable for defense and niche innovation. Full-year 2024 GAAP net income increased by \u003cstrong\u003e36%\u003c\/strong\u003e compared to 2023.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 5: Eastman Business Park Infrastructure\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCore Capability 5: Eastman Business Park Infrastructure\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e: Shared facility usage allows for cost absorption across Kodak's operations (film, chemicals) and tenants, improving overall fixed cost efficiency. The park generated $11 million in external revenue in 2020, with estimates for the year ended December 31 reaching $14 million to $15 million. Currently, an estimated 5,500 people are employed at the park, with 1,100 working for Kodak.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e: Moderate. Large, integrated industrial parks with existing infrastructure are not common to find or build from scratch. The campus spans 1,200 acres.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e: Moderate. Competitors would need massive capital and time to build a comparable, multi-use chemical\/manufacturing campus. The park boasts over 16 million square feet of manufacturing, lab, and office space.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e: High. They are actively using the park to modernize film operations and house new ventures. The park serves as an industrial manufacturing complex for 117 companies from around the world. Kodak's Industrial Film and Chemicals business accounted for 18% of total net revenue for the year ended December 31, 2023.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eUnit\/Context\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCampus Size\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1,200\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAcres\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Space\u003c\/td\u003e\n\u003ctd\u003eOver \u003cstrong\u003e16 million\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSquare Feet\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNumber of Tenants\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e117\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCompanies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Park Employment\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5,500\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePeople (Estimate)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKodak Employment at Park\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1,100\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePeople (Estimate)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2020 External Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$11 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUSD (Rent\/Services)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e: Sustained. It's a sunk cost asset that continuously lowers the marginal cost of their core manufacturing. Kodak reported full-year 2024 consolidated revenues of $1.043 billion.\u003c\/p\u003e\n\u003cp\u003eKey Infrastructure Capabilities:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eWastewater treatment capacity: 36 million gallons daily.\u003c\/li\u003e\n\u003cli\u003eIndustrial water supply processing: 54 million gallons each day.\u003c\/li\u003e\n\u003cli\u003ePower generation capacity: 117-megawatt plant producing electricity, steam, and chilled water.\u003c\/li\u003e\n\u003cli\u003ePower plant conversion investment: $100M to convert to natural gas, reducing $\\text{CO}_2$ emissions by 50%.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 6: Brand Equity in Analog\/Industrial Imaging\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e The name still carries weight, especially in niche B2B markets like motion picture film and industrial film, supporting AM\u0026amp;C revenue growth.\u003c\/p\u003e\n\u003cp\u003eThe Eastman Kodak Company brand is leveraged in segments contributing to its $1.043 billion in consolidated revenues for the full year 2024. The Advanced Materials \u0026amp; Chemicals (AM\u0026amp;C) segment, which includes industrial applications, showed revenue growth of 15% in the third quarter of 2025 over the prior year period. The company is the last remaining U.S. manufacturer in lithographic printing plates.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e High. The brand recognition is nearly universal, even if the consumer business is gone.\u003c\/p\u003e\n\u003cp\u003eThe company was founded in 1892. The brand equity is supported by a foundation of 79,000 worldwide patents earned over 130 years of Research \u0026amp; Development.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Low. Competitors cannot buy 130+ years of name recognition and trust overnight.\u003c\/p\u003e\n\u003cp\u003eThe brand's history spans over 130 years. The company's current focus leverages this history in specialized B2B areas.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Moderate. Management is successfully pivoting the brand's focus from consumer nostalgia to industrial necessity.\u003c\/p\u003e\n\u003cp\u003eManagement continues to execute a long-term plan focused on growth areas and operational efficiency. The year-end cash balance as of December 31, 2024, was $201 million.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. The brand acts as a trust multiplier in specialized industrial sectors.\u003c\/p\u003e\n\u003cp\u003eThe brand's established presence in industrial sectors provides a multiplier effect for new commercial ventures, such as the AM\u0026amp;C group's expansion into pharmaceutical product manufacturing.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eQ4 2024 Value (USD)\u003c\/th\u003e\n\u003cth\u003eFull Year 2024 Value (USD)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$266 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.043 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAM\u0026amp;C Segment Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$68 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross Profit Percentage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e19 percent\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e19 percent\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-End Cash Balance\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$201 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe pivot towards industrial focus is reflected in segment performance:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eAdvanced Materials \u0026amp; Chemicals (AM\u0026amp;C) Q4 2024 Revenue: \u003cstrong\u003e$68 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eAM\u0026amp;C Q4 2023 Revenue: \u003cstrong\u003e$58 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eBrand Licensing Q4 2024 Revenue: \u003cstrong\u003e$7 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eBrand Licensing Q4 2023 Revenue: \u003cstrong\u003e$5 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 7: Operational Efficiency and Margin Expansion Discipline\n\u003c\/h2\u003e\n\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003eDirectly translated to a massive Q3 2025 Operational EBITDA of \u003cstrong\u003e$29 million\u003c\/strong\u003e (up from \u003cstrong\u003e$1 million\u003c\/strong\u003e in Q3 2024), showing better profitability per dollar of sales.\u003c\/p\u003e\n\u003cp\u003eGross profit for Q3 2025 was \u003cstrong\u003e$68 million\u003c\/strong\u003e, a \u003cstrong\u003e51%\u003c\/strong\u003e increase of \u003cstrong\u003e$23 million\u003c\/strong\u003e compared to Q3 2024's \u003cstrong\u003e$45 million\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eGross profit percentage improved to \u003cstrong\u003e25%\u003c\/strong\u003e in Q3 2025, up \u003cstrong\u003e8 percentage points\u003c\/strong\u003e from \u003cstrong\u003e17%\u003c\/strong\u003e in Q3 2024.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003ctd\u003eQ3 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$269 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$261 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross Profit\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$68 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$45 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross Profit Percentage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e25%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e17%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperational EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$29 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003eModerate. The achievement of a \u003cstrong\u003e51%\u003c\/strong\u003e year-over-year jump in gross profit in Q3 2025 is a significant, though not unique, accomplishment in the industrial sector.\u003c\/p\u003e\n\u003cp\u003ePrint Operational EBITDA increased by \u003cstrong\u003e$17 million\u003c\/strong\u003e year-over-year, moving from negative \u003cstrong\u003e$9 million\u003c\/strong\u003e in Q3 2024 to positive \u003cstrong\u003e$8 million\u003c\/strong\u003e in Q3 2025.\u003c\/p\u003e\n\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003eLow. This performance is attributed to focused management actions.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAM\u0026amp;C segment revenue and Operational EBITDA increase driven by \u003cstrong\u003eprice increases\u003c\/strong\u003e and higher volumes in Industrial Film and Chemicals and Motion Picture.\u003c\/li\u003e\n\u003cli\u003ePrint Operational EBITDA improvement attributed to \u003cstrong\u003eprice increases\u003c\/strong\u003e, lower aluminum costs, and lower SG\u0026amp;A costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003eHigh. Results confirm organizational alignment around efficiency goals.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreviously Disclosed Going Concern Conditions Have Been Fully Resolved\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eExpected reversion amount from the U.S. pension plan increased from \u003cstrong\u003e$500 million\u003c\/strong\u003e to \u003cstrong\u003e$600 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe quarter-end cash balance on September 30, 2025, was \u003cstrong\u003e$168 million\u003c\/strong\u003e, an increase of \u003cstrong\u003e$13 million\u003c\/strong\u003e from June 30, 2025, driven by improved profitability from operations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003eTemporary. The current strength requires constant vigilance to maintain against inflationary pressures and cost fluctuations.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003e$29 million\u003c\/strong\u003e Operational EBITDA in Q3 2025 compares to \u003cstrong\u003e$26 million\u003c\/strong\u003e for the full year 2024.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 8: Motion Picture and Industrial Film Production\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCore Capability 8: Motion Picture and Industrial Film Production\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e A profitable, high-margin legacy business that supports the AM\u0026amp;C segment's revenue growth and utilizes existing infrastructure.\u003c\/p\u003e\n\u003cp\u003eThe Advanced Materials \u0026amp; Chemicals (AM\u0026amp;C) segment, which includes Motion Picture and Industrial Film, demonstrated significant financial performance in the third quarter of 2025.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eQ3 2025 Actual\u003c\/td\u003e\n\u003ctd\u003eQ3 2024 Actual\u003c\/td\u003e\n\u003ctd\u003eChange ($)\u003c\/td\u003e\n\u003ctd\u003eChange (%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAM\u0026amp;C Revenues\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$82 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$71 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$11 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e15%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAM\u0026amp;C Operational EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$16 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$10 million increase\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe increase in AM\u0026amp;C revenues and Operational EBITDA for the quarter ended September 30, 2025, was primarily driven by price increases and higher volumes in Industrial Film and Chemicals and Motion Picture.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e High. They are one of the very few global suppliers left for high-quality film stock.\u003c\/p\u003e\n\u003cp\u003eFuji stopped production of motion picture film in \u003cstrong\u003e2013\u003c\/strong\u003e, leaving Kodak as the last major producer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e High. The specialized chemical processes and quality control for film are extremely difficult to restart or replicate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High. They are actively modernizing the film manufacturing facility and launching new still film products.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEastman Kodak temporarily paused all film production in late \u003cstrong\u003e2024\u003c\/strong\u003e (specifically \u003cstrong\u003eNovember\u003c\/strong\u003e) to modernize their plant and invest in the long-term viability of film production.\u003c\/li\u003e\n\u003cli\u003eThe company continued to invest in its manufacturing process during the shutdown.\u003c\/li\u003e\n\u003cli\u003eThe company has a massive, large apprentice program with \u003cstrong\u003efour years\u003c\/strong\u003e of training for new film technicians.\u003c\/li\u003e\n\u003cli\u003eThe CEO indicated that investment in a new lab and manufacturing facility (within AM\u0026amp;C scope) is \u003cstrong\u003e'in the tens of millions of dollars.'\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. This niche market has very few viable competitors left globally.\u003c\/p\u003e\n\u003cp\u003eThe film business continues to grow, and the company is investing in additional capacity to meet demand.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eEastman Kodak Company (KODK) - VRIO Analysis: Core Capability 9: Pension Reversion Proceeds\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCore Capability 9: Pension Reversion Proceeds\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Expected net proceeds realized of approximately \u003cstrong\u003e$767 million\u003c\/strong\u003e reverted to the company from the KRIP, providing a massive, non-operational cash infusion to significantly reduce debt and strengthen the balance sheet.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e High. The final reversion of \u003cstrong\u003e$1.023 billion\u003c\/strong\u003e in total excess assets, resulting in \u003cstrong\u003e$767 million\u003c\/strong\u003e for the company, is a rare, one-time financial catalyst, exceeding prior estimates of \u003cstrong\u003e$500 million\u003c\/strong\u003e to \u003cstrong\u003e$600 million\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Not Applicable. This is a financial event realized from a historical defined benefit plan structure, not an operational capability to be imitated. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High. The process was completed on December 2, 2025, with all KRIP obligations settled and a new KCBP funded.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary. This is a one-time financial boost, not a source of ongoing operational advantage. \u003c\/p\u003e\n\u003cp\u003eThe financial impact of the completed reversion is detailed below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFinancial Metric\u003c\/th\u003e\n\u003cth\u003eAmount (USD)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Excess Pension Assets (KRIP)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.023 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAssets Reverted to Company (Cash \u0026amp; Non-Cash)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$767 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash Proceeds Received\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$609 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-Cash Assets Reverted\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$158 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProceeds Used to Pre-pay Term Loans\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$312 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemaining Term Loan Balance\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$200 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFunding for New KCBP (Cash \u0026amp; Investment Assets)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$256 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExcise Taxes Required\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$153 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiabilities Transferred to PBGC\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$13 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected Post-Transaction Cash Balance\u003c\/td\u003e\n\u003ctd\u003eExceeding \u003cstrong\u003e$300 million\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe company's immediate financial focus includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDraft 13-week cash view by Friday.\u003c\/li\u003e\n\u003cli\u003eMaintaining a net-positive cash position.\u003c\/li\u003e\n\u003cli\u003eReducing ongoing interest expense from lower debt.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516195004565,"sku":"kodk-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/kodk-vrio-analysis.png?v=1740168718","url":"https:\/\/dcf-analysis.com\/products\/kodk-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}